Comment on: Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 3, 2011, Pages 684-685

  Castanheira, Mariana ^a   Deshpande, Lalitagauri M ^a   Mendes, Rodrigo E ^a   Rodriguez Noriega, Eduardo ^b   Jones, Ronald N ^a   Morfin Otero, Rayo ^b  

^a JMI LABORATORIES   (United States)

^b Instituto de Patologia Infecciosa y Experimental   (Mexico)

Author keywords

Antimicrobial resistance; Enterobacteriaceae; MBLs

Indexed keywords

AMPICILLIN; ARGININE; AZTREONAM; BETA LACTAMASE VIM 23; CARBAPENEM; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; DORIPENEM; ERTAPENEM; GENTAMICIN; HYDROLASE; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; POLYMYXIN B; SULFAMETHOXAZOLE; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BROTH DILUTION; ENTEROBACTERIACEAE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ESCHERICHIA COLI; INTEGRON; LETTER; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EVOLUTION; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PSEUDOMONAS AERUGINOSA;

ADOLESCENT; AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; CATALYTIC DOMAIN; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; EVOLUTION, MOLECULAR; HUMANS; MALE; MEXICO; MICROBIAL SENSITIVITY TESTS; MUTANT PROTEINS;

EID: 79951547071     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq393     Document Type: Letter

References (6)

1. Merino M, Pérez-Llarena FJ, Kerff F et al. Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases. J Antimicrob Chemother 2010; 65: 1950-4.
2. Samuelsen O, Castanheira M, Walsh TR et al. Kinetic characterization of VIM-7, a divergent member of the VIM metallo-β-lactamase family. Antimicrob Agents Chemother 2008; 52: 2905-8.
3. Garcia-Saez I, Docquier JD, Rossolini GM et al. The three-dimensional structure of VIM-2, α Zn-β-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form. J Mol Biol 2008; 375: 604-11.
4. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Eighth Edition: Approved Standard M07-A8. CLSI, Wayne, PA, USA, 2009.
5. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement: M100-S20-U. CLSI, Wayne, PA, USA, 2010.
6. Morfin-Otero R, Rodriguez-Noriega E, Deshpande LM et al. Dissemination of a blaVIM-2-carrying integron among Enterobacteriaceae species in Mexico: report from the SENTRY Antimicrobial Surveillance Program. Microb Drug Resist 2009; 15: 33-5.